Cx Precision Medicine, Inc. — Form D
Cx Precision Medicine, Inc. of FORTH WORTH, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-13. The offering totals $3.0M, of which $1.2M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-12-13
- Form: D
- Accession: 0001681655-22-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.2M
- Remaining: $1.8M
- Investors: 25
- Date of first sale: 2022-12-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-467234
Issuer
- Name: Cx Precision Medicine, Inc.
- CIK: 0001681655
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 1660 S. UNIVERSITY DR., #1216, FORTH WORTH, TX, 76107
- Phone: 8175231301
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Jeff Keyser | Director | San Carlos, CA |
| Robert Ferguson | Executive Officer | Tacoma, WA |
| Edward Lasater | Executive Officer | Fort Worth, TX |
| Robert Ferguson | Director | Tacoma, WA |
| Darlene Jeff Boudreaux | Executive Officer | Fort Worth, TX |
| Cameron Cushman | Director | Fort Worth, TX |
| Danguole Altman | Director | Houston, TX |
| Danguole Altman | Executive Officer | Houston, TX |
| Edward Lasater | Director | Fort Worth, TX |
| Donald Jeff Keyser | Director | Southlake, TX |
| Frank Gerome | Director | Fort Worth, TX |
| Frank Gerome | Executive Officer | Fort Worth, TX |
Other filings by this issuer (4)
More